MoneyWorks4Me

Dipna Pharmachem submits intimation of in-principle approval for rights issue

18 Jan 2024 Evaluate
Dipna Pharmachem has informed that pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, the exchange has issued In-principle approval vide Ref: LOD/RIGHT/CP/FIP/1109/2023-24 dated 17th January, 2024 for the proposed rights issue. The In-principle approval letter received from the Stock Exchange i.e. BSE is enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers